Good tolerance in newborns of two specific probiotic strains from Probi[®]
Probi[®] has performed one of the first tolerance studies with both a L. plantarum strain and a L. rhamnosus strain in a newborn population. L. plantarum has not been studied in an infant population this young before. The youngest baby in the study was recruited already at 4 days of age and started consuming probiotics at 11 days of age. The primary objective of this parallel, double blind, randomized, placebo-controlled pilot study was to evaluate the tolerance of L. plantarum HEAL9 (HEAL9[TM]) and L. rhamnosus 271 in healthy infants. The study has now been published. https://pubmed.